Bg pattern

XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Xevudy 500 mg concentrate for solution for infusion

sotrovimab

This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of section 4 will tell you how to report side effects.

Read all of this leaflet carefully before you are given this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Xevudy and what is it used for
  2. What you need to know before you are given Xevudy
  3. How Xevudy is given
  4. Possible side effects
  5. Storage of Xevudy
  6. Contents of the pack and other information

1. What is Xevudy and what is it used for

Xevudy contains the active substance sotrovimab. Sotrovimab is a monoclonal antibody, a type of protein modified to recognize a specific target on the SARS-CoV-2 virus, the virus that causes COVID-19.

Xevudy is used to treat COVID-19 in adults and adolescents (from 12 years of age and weighing at least 40 kg). It targets the spike protein that the virus uses to attach to cells, preventing the virus from entering the cell and producing new viruses. By preventing the virus from multiplying in the body, Xevudy can help your body overcome the infection and prevent serious illness.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Xevudy

You must not be given Xevudy

  • if you are allergic to sotrovimab or any of the other ingredients of this medicine (listed in section 6).
  • Tell your doctorif you think this applies to you.

Warnings and precautions

Allergic reactions

Xevudy can cause allergic reactions.

  • See "Allergic reactions" in Section 4.

Infusion-related reactions

Xevudy can cause infusion-related reactions.

  • See "Infusion-related reactions" in Section 4.

Children and adolescents

Xevudy must not be given to children or adolescents under 12 years of age or weighing less than 40 kg.

Other medicines and Xevudy

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnantor are planning to have a baby, ask your doctorfor advice before being given Xevudy. Your doctor will decide if the benefits of treatment with Xevudy outweigh the potential risks to you and your baby.

It is not knownif the components of Xevudy can pass into breast milk. If you are breastfeeding, ask your doctorfor advice before being given Xevudy.

Driving and using machines

Xevudy is not expected to affect your ability to drive or use machines.

Xevudy contains polysorbate

This medicine contains 4.8 mg of polysorbate 80 in each 500 mg dose. Polysorbates may cause allergic reactions. Tell your doctor if you have any known allergy.

3. How Xevudy is given

The recommended dose for adults and adolescents (12 years of age or older and weighing at least 40 kg) is:

  • 500 mg (one vial)

The medicine will be prepared in a solution and given to you by drip (infusion) into a vein by a doctor or nurse. It takes up to 30 minutes to give you the full dose of the medicine. You will be monitored during and for at least 1 hour after the treatment.

The "Instructions for healthcare professionals" below provide details for your doctor, pharmacist or nurse on how to prepare and administer the infusion of Xevudy.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Allergic reactions

Allergic reactions to Xevudy are commonand affect up to 1 in 10 people.

Rarely, these allergic reactions can be serious (anaphylaxis), affecting up to 1 in 1,000 people (rare). If you get any of the following symptoms after being given Xevudy, you may be having an allergic reaction and should seek medical help immediately:

  • skin rash, like hives or redness of the skin
  • itching
  • swelling, sometimes of the face or mouth (angioedema)
  • increased wheezing (high-pitched sound when breathing), cough or difficulty breathing
  • sudden feeling of weakness or dizziness (which can cause loss of consciousness or falls)

Infusion-related reactions

It is commonfor infusion-related reactions to occur when receiving an infusion, affecting up to 1 in 10 people. These reactions usually develop within minutes or hours but can appear up to 24 hours after treatment or later. The following symptoms are possible. If you get any of these symptoms after being given Xevudy, you may be having an infusion-related reaction and should seek medical help immediately:

  • redness of the skin (flushing)
  • chills
  • fever
  • difficulty breathing
  • fast heart rate
  • low blood pressure

Other side effects

Uncommon (may affect up to 1 in 100 people)

  • shortness of breath (dyspnoea).

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Xevudy

Healthcare professionals are responsible for storing this medicine and disposing of any unused product correctly.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of the month shown.

Do not freeze.

Before dilution:

  • store in a refrigerator (2°C to 8°C)
  • store in the original package to protect from light.

Once diluted, this medicine should be used immediately. If immediate administration is not possible after dilution, the diluted solution can be stored at room temperature (up to 25°C) for up to 6 hours or in a refrigerator (2°C to 8°C) for up to 24 hours from the time of dilution until administration is complete.

6. Contents of the pack and other information

What Xevudy contains

  • The active substance is sotrovimab. Each vial contains 500 mg of sotrovimab in 8 ml of concentrate.
  • The other ingredients are histidine, histidine hydrochloride, sucrose, polysorbate 80 (E 433) (see section 2 "Xevudy contains polysorbate"), methionine and water for injections.

Appearance and pack

Xevudy is a clear, colourless or yellow to brown liquid presented in a single-use glass vial with a rubber stopper and a removable aluminium seal. Each pack contains one vial.

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited

12 Riverwalk

Citywest Business Campus

Dublin 24

D24 YK11

Ireland

Manufacturer

GlaxoSmithKline Manufacturing S.p.A.

Strada Provinciale Asolana, 90,

43056 San Polo di Torrile, Parma

Italy

You can request more information about this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

GlaxoSmithKline Pharmaceuticals s.a./n.v.

Tél/Tel: + 32 (0) 10 85 52 00

Lietuva

GlaxoSmithKline Trading Services Limited

Tel: + 370 80000334

Text in Bulgarian language with contact information of GlaxoSmithKline Trading Services Limited and phone number

Luxembourg/Luxemburg

GlaxoSmithKline Pharmaceuticals s.a./n.v.

Belgique/Belgien

Tél/Tel: + 32 (0) 10 85 52 00

Ceská republika

GlaxoSmithKline, s.r.o.

Tel: + 420 222 001 111

[email protected]

Magyarország

GlaxoSmithKline Trading Services Limited.

Tel: + 36 80088309

Danmark

GlaxoSmithKline Pharma A/S

Tlf.: + 45 36 35 91 00

[email protected]

Malta

GlaxoSmithKline Trading Services Limited.

Tel: + 356 80065004

Deutschland

GlaxoSmithKline GmbH & Co. KG

Tel.: + 49 (0)89 36044 8701

[email protected]

Nederland

GlaxoSmithKline BV

Tel: + 31 (0)33 2081100

Eesti

GlaxoSmithKline Trading Services Limited.

Tel: + 372 8002640

Norge

GlaxoSmithKline AS

Tlf: + 47 22 70 20 00

Ελλάδα

GlaxoSmithKline Μονοπρ?σωπη A.E.B.E.

Τηλ: + 30 210 68 82 100

Österreich

GlaxoSmithKline Pharma GmbH

Tel: + 43 (0)1 97075 0

[email protected]

España

GlaxoSmithKline, S.A.

Tel: + 34 900 202 700

[email protected]

Polska

GSK Services Sp. z o.o.

Tel.: + 48 (0)22 576 9000

France

Laboratoire GlaxoSmithKline

Tél: + 33 (0)1 39 17 84 44

[email protected]

Portugal

GlaxoSmithKline – Produtos Farmacêuticos, Lda.

Tel: + 351 21 412 95 00

[email protected]

Hrvatska

GlaxoSmithKline Trading Services Limited

Tel: +385 800787089

România

GlaxoSmithKline Trading Services Limited

Tel: + 40800672524

Ireland

GlaxoSmithKline (Ireland) Limited

Tel: + 353 (0)1 4955000

Slovenija

GlaxoSmithKline Trading Services Limited

Tel: + 386 80688869

Ísland

Vistor ehf.

Sími: + 354 535 7000

Slovenská republika

GlaxoSmithKline Trading Services Limited

Tel: + 421 800500589

Italia

GlaxoSmithKline S.p.A.

Tel: + 39 (0)45 7741111

Suomi/Finland

GlaxoSmithKline Oy

Puh/Tel: + 358 (0)10 30 30 30

Κ?προς

GlaxoSmithKline Trading Services Limited

Τηλ: + 357 80070017

Sverige

GlaxoSmithKline AB

Tel: + 46 (0)8 638 93 00

[email protected]

Latvija

GlaxoSmithKline Trading Services Limited

Tel: + 371 80205045

Date of last revision of this leaflet

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu, and on the Spanish Agency of Medicines and Health Products (AEMPS) web site (http://www.aemps.gob.es/).

-------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals.

For more information, see the Summary of Product Characteristics.

Treatment should be prepared by a qualified healthcare professional using aseptic technique.

Traceability

In order to improve the traceability of biological medicinal products, the name and batch number of the administered product should be clearly recorded.

Preparation of the dilution

  1. Remove a vial of sotrovimab from the refrigerator (2°C to 8°C). Allow the vial to reach room temperature, protected from light, for approximately 15 minutes.
  2. Visually inspect the vial to ensure it is free from particles and that there is no visible damage to the vial. If the vial is identified as unusable, discard it and restart preparation with a new vial.
  3. Gently rotate the vial in circles several times before use without creating air bubbles. Do not shake or vigorously agitate the vial.

Dilution instructions

  1. Withdraw and discard 8 ml from a 50 ml or 100 ml infusion bag containing 9 mg/ml (0.9%) sodium chloride solution for infusion or 5% glucose solution for infusion.
  2. Withdraw 8 ml of sotrovimab from the vial.
  3. Inject the 8 ml of sotrovimab into the infusion bag through the septum.
  4. Discard any unused solution remaining in the vial. The vial is for single use only and should only be used for one patient.
  5. Before infusion, gently move the infusion bag back and forth 3 to 5 times. Do not invert the infusion bag. Avoid the formation of air bubbles.

The diluted sotrovimab solution should be used immediately. If immediate administration is not possible after dilution, the diluted solution can be stored at room temperature (up to 25°C) for up to 6 hours or in a refrigerator (2°C to 8°C) for up to 24 hours from the time of dilution until administration is complete.

Administration instructions

  1. Connect an infusion set to the infusion bag using a standard diameter tube. It is recommended to administer the dosing solution intravenously with an in-line filter of 0.2 μm.
  2. Prepare the infusion set.
  3. Administer as an intravenous infusion over 15 minutes (when using a 50 ml infusion bag) or 30 minutes (when using a 100 ml infusion bag) at room temperature.

Disposal

Disposal of unused medicinal product and all materials that have come into contact with it should be done in accordance with local regulations.

Online doctors for XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance. His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation. Patients commonly consult Dr Daniel Cichi for: 

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • sexually transmitted infections, erectile dysfunction;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders, weight loss, hair loss;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.

Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.

Camera Book a video appointment
€55
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
The active ingredient in XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION is sotrovimab. This information helps identify medicines with the same composition but different brand names.
Who manufactures XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION is manufactured by Glaxosmithkline Trading Services Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to XEVUDY 500 MG CONCENTRATE FOR INFUSION SOLUTION?
Other medicines with the same active substance (sotrovimab) include BEYFORTUS 100 mg injectable solution in pre-filled syringe, BEYFORTUS 50 mg Injectable Solution in Pre-filled Syringe, EVUSHELD 150 MG +150 MG INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media